Skip to main content
ESTA
NASDAQ Industrial Applications And Services

Establishment Labs Q2 Revenue Jumps 32%, Loss Narrows; Refinances Debt with $300M Oaktree Facility

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$77.42
Mkt Cap
$2.279B
52W Low
$33.35
52W High
$97.59
52W Position info
132% above low
Off High info
21% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

ESTA has more than doubled off its 52-week low of $33.35.

Summary

Establishment Labs reported Q2 2026 revenue of $67.5 million, up 31.7% year-over-year, with a narrower net loss and improved gross margins. The company also refinanced its debt with a $300 million Oaktree facility, drawing $265 million, and disclosed two director 10b5-1 trading plans.


Key Events · Earnings and Guidance · ESTA

  • Q2 Revenue Surges 32%

    Revenue reached $67.5 million, up 31.7% from $51.3 million in Q2 2025, driven by a $14.4 million increase in U.S. sales as Motiva implant adoption accelerates.

  • Loss Narrows, Margins Expand

    Net loss improved to $11.7 million from $16.6 million a year ago. Gross margin expanded to 70.6% from 68.8%, reflecting a favorable geographic mix and higher U.S. pricing.

  • $300M Debt Refinancing Completed

    On April 30, 2026, the company entered an amended $300 million Oaktree credit facility, drawing $265 million at 8.75% interest. The company elected to pay 100% of interest in kind through Q2 2026, preserving cash.

  • Cash Position and Liquidity

    Cash and equivalents stood at $71.2 million as of June 30, 2026. The company states it has sufficient liquidity for at least the next 12 months, supported by improving operations and the new debt facility.


Analysis · ESTA · Industrial Applications And Services

A strong second quarter saw revenue climb 31.7% to $67.5 million, fueled by accelerating U.S. adoption of Motiva breast implants. Gross margins expanded to 70.6%, and the net loss narrowed to $11.7 million from $16.6 million a year ago. The company also refinanced its debt with a new $300 million Oaktree facility, drawing $265 million at 8.75% interest, and elected to pay interest in kind to preserve cash. While the debt load is substantial, the improved operating performance and extended maturity to 2031 reduce near-term liquidity risk. Two directors adopted 10b5-1 trading plans, a routine but notable insider selling signal.

At the time of this filing, ESTA was trading at $77.42 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.3B. The 52-week trading range was $33.35 to $97.59. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ESTA - Latest Insights

ESTA
Aug 06, 2026, 8:10 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $91.18
Real-time Price: $77.42 info
Change: -$13.76 (-15%) info
Market Cap: $2.279B info
ESTA
Aug 06, 2026, 8:04 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $90.82
Real-time Price: $77.42 info
Change: -$13.40 (-15%) info
Market Cap: $2.279B info
ESTA
Jun 29, 2026, 8:05 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $89.99
Real-time Price: $77.42 info
Change: -$12.57 (-14%) info
Market Cap: $2.279B info
ESTA
May 08, 2026, 4:08 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $71.77
Real-time Price: $77.42 info
Change: +$5.65 (+8%) info
Market Cap: $2.279B info
ESTA
May 06, 2026, 8:08 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $73.00
Real-time Price: $77.42 info
Change: +$4.42 (+6%) info
Market Cap: $2.279B info